Clinical Trial for Sickle Cell Disease. | Pfizer

The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of GBT021601.

Closest Location

To find study locations, use the location search box below.

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

Sickle Cell Disease

Sex

Male or Female

Age

6 months - 65 years

View more eligibility criteria on ClinicalTrials.gov

Study Locations

Location

Distance

Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center

Torrance, California, United States, 90502

Recruiting

Edward Jenner Research Group, LLC

Plantation, Florida, United States, 33317

Recruiting

Palm Beach Children's Hospital

West Palm Beach, Florida, United States, 33407

Recruiting

Alpha Clinical Research of Georgia LLC

Atlanta, Georgia, United States, 30312

Recruiting

Our Lady of the Lake Regional Medical Center

Baton Rouge, Louisiana, United States, 70808

Recruiting

University Medical Center, New Orleans

New Orleans, Louisiana, United States, 70112

Recruiting

Mississippi Center for Advanced Medicine

Madison, Mississippi, United States, 39110

Recruiting

The University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030

Recruiting

Inova Center for Personalized Health

Fairfax, Virginia, United States, 22031

Recruiting

Gertrude's Children's Hospital

Nairobi, Kenya, 42325

Recruiting

Lagos University Teaching Hospital Haematology

Idi Araba, Lagos, Nigeria

Recruiting

Aminu Kano Teaching Hospital

Kano, Nigeria

Recruiting

University College Hospital

Oyo, Nigeria

Recruiting